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Abstracts: The 16th International Congress on Nutrition and Metabolism in Renal Disease 2012 A53malnutrition were observed in 48% of the subjects. Malnutrition was
present in 64% (21/33) of the overweight patients and in 91% (10/11) of the
obese patients. Transplantation vintage was directly associated with fat
mass and inversely associated with LBM. Malnourished patients (SGA) had a
longer transplantation vintage. Adiponectin levels were signiﬁcantly lower
in transplanted patients as compared to controls. In multivariate analysis,
leptin was an independent predictor of serum creatinine level and of eGFR..
The prevalence of concurrent signs of overweight/obesity and malnutrition
in the kidney transplant recipients is high
http://dx.doi.org/10.1016/j.krcp.2012.04.469146
PARTIALLY HYDROLYZED GUAR GUM INTAKE AMELIORATES
CONSTIPATION, IMPROVES NUTRITIONAL STATUS AND REDUCES
INDOXYLSULFURIC ACID IN DIALYSIS PATIENTS.
Hiroto Maeda, Tomoko Uemura, Makoto Nasu, Natsumi Iwata,
Junko Yoshimura, Shoji Sakai
Shimonoseki City Hospital, Yamaguchi, Japan
Dialysis patients often develop constipation and changes in intestinal
bacterial ﬂora. Indoxylsulfuric acid (IS) levels rise as glomerular ﬁltration
decreases, and patients with renal failure have high IS. Elevated IS is also
caused by increased indole due to altered intestinal ﬂora (Takayama et al,
Am J Kidney Dis. 2003). We investigated whether administering partially
hydrolyzed guar gum (PHGG) (Sunﬁber: a product of Taiyokagaku Co., Ltd.,
Japan) ameliorates constipation and improves nutritional status in dialysis
patients, while decreasing IS levels. Thirty-ﬁve patients on maintenance
dialysis (mean age, 71 7 9; male/female¼ 22/13) ingested PHGG (10 g/
day) for 6 weeks. Defecation was scored before and after PHGG intake
using a modiﬁed Constipation Assessment Scale-Long Term (Japanese
version). Nutritional status was rated according to the Geriatric Nutritional
Risk Index (GNRI) before and after PHGG intake. IS was measured in
8 patients taking PHGG orally for 24 weeks, for comparison with those in
8 patients not on PHGG. Constipation scores decreased from 7.9 to 5.0 (p /
.01) and GNRI increased from 95.0 7 5.0 to 95.9 7 5.7 (p /.05), reﬂecting
amelioration of constipation and improved nutritional status. The ratio of
IS after to that before PHGG intake was calculated to analyze the
magnitude of IS change. The ratio in patients not on PHGG was 1.2 7 0.3,
i.e. IS rose, while that in patients taking PHGG was signiﬁcantly reduced
(0.8 7 0.3, p /.05). Our results indicate PHGG consumption to ameliorate
constipation and improve nutritional status, and that continued intake
reduces IS, in dialysis patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.470147
ASSOCIATION BETWEEN HANDGRIP STRENGTH AND INFLAMMATION IN
HEMODIALYSIS PATIENTS
Viviane O Leal, Milena B Stockler-Pinto, Julie C Lobo, Najla E Farage, Luiz
A Anjos, Denise Mafra
Programa de pos-graduac- ~ao em Ciencias Medicas, Universidade Federal
Fluminense (UFF), Niteroi - RJ, Brazil.
The inﬂammation is a common feature in HD patients and may
contribute to muscle wasting. Handgrip strength (HGS) has been
recognized as a useful tool in assessing muscle function in hemodialysis
(HD) patients. The aim of this study was to evaluate the association
between inﬂammation and muscle function in HD patients. Twenty-three
HD patients (19 men, 54.3712.4 years of age, BMI, 24.574.6kg/m2) were
studied. HGS was measured 3x with a mechanical dynamometer after the
HD sessions. HGS values less than the 10th percentile of an age-, gender-and regional speciﬁc reference were considered as muscle function loss.
Tumoral necrosis factor-a (TNF-a) and interleukin-6 (IL-6) levels were
determined by a multiplex assay kit through the device Luminex method.
C-reactive protein (CRP) was measured with the immunoturbidimetric
method. HGS values were signiﬁcantly greater in males (28.879.7 kg) than
females (13.976.5kg) (p o0.0001) and, 57.6% of the HD patients
presented muscle function loss. TNF-a, IL-6 and CRP levels were
5.671.7pg/mL, 3.5 (1.75) pg/mL and 0.17 (0.50) mg/dL, respectively.
According to the CRP levels, 42.4% of the HD patients presented
inﬂammation (CRP 4 0.3mg/dL). CRP and IL-6 were not correlated with
HGS, but TNF-a were inversely correlated with HGS (r ¼
-0.42; p ¼ 0.01). These data suggest that inﬂammation can play an
important role on muscle function in HD patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.471148
URIC ACID LEVELS CORRELATES WITH INFLAMMATORY MARKERS AND
ADHESION MOLECULES IN HEMODIALYSIS PATIENTS
Julie Calixto Lobo, Antonio Claudio Lucas, da Nobrega, Jose Carlos Carraro-
Eduardo, Denise Mafra
Programa de pos-graduac- ~ao em Ciencias Medicas, Universidade Federal
Fluminense (UFF), Niteroi - RJ, Brazil.
Elevated serum uric acid has been associated to a variety of
cardiovascular disease states and with systemic inﬂammation. The aim of
this study was to analyze the association between uric acid levels and
inﬂammatory markers in hemodialysis (HD) patients. This cross-sectional
study included 50 HD patients (62% men, 54.3712.6 yrs, BMI 24.474 Kg/
m2) and 21 healthy individuals (45% men, 50.7715.7 yrs, BMI
25.574.0 Kg/m2). Uric acid was measured using uricase-PAP method,
inﬂammatory (TNF-a, IL-6 and CRP) and atherosclerosis markers (ICAM-1,
VCAM-1, MCP-1 and PAI-1) were measured by a multiplexed particle-
based ﬂow cytometric assay. There was a positive correlation between
serum uric acid and inﬂammatory markers, IL-6 (r¼0.30, p¼0.01), CRP
(r¼0.37, p¼0.003), TNF-a (r¼0.40, p¼0.001) and adhesion molecules
levels, ICAM-1 (r¼0.53, p¼0.0001), and VCAM-1 (r¼0.45, p¼0.0001)Parameters HD Patients Healthy individualsCRP (mg/mL) 0.32 7 0.30* 0.11 7 0.12
TNF-a (pg/mL) 5.5 7 2.1* 2.4 7 1.1
IL-6 (pg/mL) 4.1 7 1.6* 2.7 7 0.4
PAI-1 (ng/mL) 7.0 7 2.7 6.2 7 2.1
MCP-1 (pg/ml) 47.6 7 24.2 37.3 7 19.0
VCAM-1 (ng/mL) 48.5 7 8.5* 23.8 7 5.5
ICAM-1 (ng/mL) 20.5 7 15.9* 7.2 7 1.2n
po0.05
